Working… Menu

Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01837095
Recruitment Status : Completed
First Posted : April 22, 2013
Last Update Posted : September 14, 2018
Information provided by (Responsible Party):
Polyphor Ltd.